Washington, DC 20549



FORM 12b-25





☐ Form 10-K  ☐ Form 20-F  ☐ Form 11-K  ☒ Form 10-Q  ☐ Form 10-D  ☐ Form N-CEN  ☐ Form N-CSR


For the Period Ended: March 31, 2024


☐ Transition Report on Form 10-K

☐ Transition Report on Form 20-F

☐ Transition Report on Form 11-K

☐ Transition Report on Form 10-Q


For the Transition Period Ended:                                              


Nothing in this Form shall be construed to imply that the Commission has verified any information contained herein.


If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:









America Great Health


Full Name of Registrant


Former Name if Applicable


1609 W. Valley Blvd., #338A


Address of Principal Executive Office (Street and Number)


Alhambra, CA 91803


City, State and Zip Code



PART II - RULES 12b-25 (b) and (c)


If the subject report could not be filed without reasonable effort or expense and the Company seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)


The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;



The subject annual report, semi-annual report, transition report on Form10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and



The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable




State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.


The Company has not been able to compile the requisite financial data and other narrative information necessary to enable it to complete the Company’s Quarterly Report on Form 10-Q by May 15, 2024 without unreasonable effort and expense.







(1) Name and telephone number of person to contact in regard to this notification:


Mike Wang




(Area code)

(Telephone Number)


(2) Have all other periodic reports required under section 13 or 15(d) of the Securities Exchange Act of 1934 or section 30 of the Investment Company act of 1940 during the preceding 12 months or for such shorter period that the Company was required to file such report(s) been filed? If the answer is no, identify report(s).     ☒ Yes   ☐ No


(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?    ☐ Yes    ☒ No


If so: attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.




America Great Health

Date: May 15, 2024


By:  /s/Mike Wang


Mike Wang






America Great Health (PK) (USOTC:AAGH)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more America Great Health (PK) Charts.
America Great Health (PK) (USOTC:AAGH)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more America Great Health (PK) Charts.